Department of Medicine (Neurology), The Ottawa Hospital, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Eric Poulin Centre for Neuromuscular Disease, University of Ottawa, Ottawa, Ontario, Canada.
Muscle Nerve. 2022 Apr;65(4):400-404. doi: 10.1002/mus.27466. Epub 2021 Dec 21.
Laryngospasm is an involuntary, sustained closure of sphincter musculature that leads to an unpleasant subjective experience of dyspnea and choking. It is an underreported symptom in amyotrophic lateral sclerosis (ALS). In this study we aimed to better characterize the prevalence and clinical characteristics of laryngospasm in ALS patients.
The medical records of 571 patients with ALS followed between 2008 and 2018 were searched for evidence of laryngospasm. A total of 23 patients with laryngospasm were identified and the data related to patient and laryngospasm characteristics were extracted.
Laryngospasm was reported in 4% of ALS patients. Females comprised 57% of patients and their mean age was 63.4 years. Laryngospasm frequently manifested in patients with moderate bulbar dysfunction and seemed independent of respiratory function. Among laryngospasm patients, 26% were cigarette smokers and 13% had a history of gastroesophageal reflux. The most common reported trigger was excessive saliva irritating the vocal cords (35%) followed by eating a meal (17%). There was significant variation in laryngospasm frequency (up to 5 per hour) and duration (seconds to minutes). Most patients could not identify an effective coping mechanism, although 13% reported that drinking water was effective.
Despite its low prevalence in ALS, laryngospasm should be included in the symptom inquiry. The present findings may improve patient care through increased recognition of the clinical features of laryngospasm in ALS patients, identifying a link between laryngospasm and moderate bulbar dysfunction, and highlighting trigger avoidance as a management strategy. Additional research is required to understand the pathophysiology and optimal treatment.
喉痉挛是一种不自主的、持续性的括约肌收缩,导致呼吸困难和窒息的不愉快主观体验。它是肌萎缩侧索硬化症(ALS)中报告较少的症状。在这项研究中,我们旨在更好地描述 ALS 患者中喉痉挛的患病率和临床特征。
搜索了 2008 年至 2018 年间随访的 571 例 ALS 患者的病历,以寻找喉痉挛的证据。共发现 23 例有喉痉挛的患者,并提取了与患者和喉痉挛特征相关的数据。
喉痉挛在 4%的 ALS 患者中报告。女性占患者的 57%,平均年龄为 63.4 岁。喉痉挛常发生在中度球部功能障碍的患者中,似乎与呼吸功能无关。在喉痉挛患者中,26%为吸烟者,13%有胃食管反流病史。最常见的报告诱因是过多的唾液刺激声带(35%),其次是进食(17%)。喉痉挛的频率(高达每小时 5 次)和持续时间(数秒至数分钟)有很大差异。大多数患者无法确定有效的应对机制,尽管 13%的患者报告喝水有效。
尽管在 ALS 中患病率较低,但喉痉挛也应包括在症状询问中。目前的发现可能会通过提高对 ALS 患者喉痉挛的临床特征的认识,确定喉痉挛与中度球部功能障碍之间的联系,并强调避免诱因作为管理策略,从而改善患者的护理。需要进一步研究以了解其病理生理学和最佳治疗方法。